Dr. Kandl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4720 Waters Ave
Savannah, GA 31404Phone+1 912-629-5968Fax+1 912-629-5821
Education & Training
Rutgers New Jersey Medical SchoolResidency, Ophthalmology, 2012 - 2015
Boston University Medical CenterResidency, Internal Medicine, 2011 - 2012
Medical University of South CarolinaClass of 2011
Certifications & Licensure
GA State Medical License 2018 - 2025
SC State Medical License 2018 - 2025
TX State Medical License 2016 - 2018
AK State Medical License 2015 - 2016
NJ State Medical License 2012 - 2016- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 65 citationsImmunotherapy With Programmed Cell Death 1 Inhibitors for 5 Patients With Conjunctival Melanoma.Oded Sagiv, Sudip D. Thakar, Thomas J. Kandl, Joshua Ford, Matthew C. Sniegowski
JAMA Ophthalmology. 2018-11-01 - 38 citationsDistinct Biological Types of Ocular Adnexal Sebaceous Carcinoma: HPV-Driven and Virus-Negative Tumors Arise through Nonoverlapping Molecular-Genetic Alterations.Michael T. Tetzlaff, Jonathan L. Curry, Jing Ning, Oded Sagiv, Thomas J. Kandl
Clinical Cancer Research. 2019-02-15 - 38 citationsExtraocular Muscle Enlargement and Thyroid Eye Disease-like Orbital Inflammation Associated with Immune Checkpoint Inhibitor Therapy in Cancer Patients.Oded Sagiv, Thomas J. Kandl, Sudip D. Thakar, Bradley Thuro, Naifa L. Busaidy
Ophthalmic Plastic and Reconstructive Surgery. 2019-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
